AXIN1 and AXIN2 variants in gastrointestinal cancers

Cancer Letters

Volumn 355, Issue 1, 2014, Pages 1-8

  Mazzoni, Serina M ^a   Fearon, Eric R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Beta catenin; Colon cancer; Gastric cancer; Hepatocellular carcinoma; Wnt signaling

Indexed keywords

AXIN; BETA CATENIN; PROTEIN AXIN1; PROTEIN AXIN2; UNCLASSIFIED DRUG; WNT PROTEIN; AXIN1 PROTEIN, HUMAN; AXIN2 PROTEIN, HUMAN;

AXIN1 GENE; AXIN2 GENE; CARCINOGENESIS; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; EXON; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GERM LINE; HEPATOBLASTOMA; HETEROZYGOSITY; HUMAN; LIVER CELL CARCINOMA; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; SHORT SURVEY; SIGNAL TRANSDUCTION; SOMATIC MUTATION; STOMACH CARCINOMA; AMINO ACID SEQUENCE; ANIMAL; GASTROINTESTINAL TUMOR; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; MUTATION; PATHOLOGY; PHENOTYPE; RISK FACTOR; WNT SIGNALING PATHWAY;

AMINO ACID SEQUENCE; ANIMALS; AXIN PROTEIN; CARCINOMA, HEPATOCELLULAR; GASTROINTESTINAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; RISK FACTORS; WNT SIGNALING PATHWAY;

EID: 84907969130     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.09.018     Document Type: Review

References (72)

1. Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337.
2. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:589-600.
3. Kinzler K.W., Nilbert M.C., Su L.K., Vogelstein B., Bryan T.M., Levy D.B., et al. Identification of FAP locus genes from chromosome 5q21. Science 1991, 253:661-665.
4. Munemitsu S., Albert I., Souza B., Rubinfeld B., Polakis P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl Acad. Sci. U.S.A. 1995, 92:3046-3050.
5. Hart M.J., de los Santos R., Albert I.N., Rubinfeld B., Polakis P. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr. Biol 1998, 8:573-581.
6. Kishida S., Yamamoto H., Ikeda S., Kishida M., Sakamoto I., Koyama S., et al. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J. Biol. Chem 1998, 273:10823-10826.
7. Xing Y., Clements W.K., Kimelman D., Xu W. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex. Genes Dev 2003, 17:2753-2764.
8. Behrens J., Jerchow B.A., Wurtele M., Grimm J., Asbrand C., Wirtz R., et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998, 280:596-599.
9. Yamamoto H., Kishida S., Uochi T., Ikeda S., Koyama S., Asashima M., et al. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos. Mol. Cell. Biol 1998, 18:2867-2875.
10. Peifer M., Pai L.M., Casey M. Phosphorylation of the Drosophila adherens junction protein Armadillo: roles for wingless signal and zeste-white 3 kinase. Dev. Biol 1994, 166:543-556.
11. Yamamoto H., Kishida S., Kishida M., Ikeda S., Takada S., Kikuchi A. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J. Biol. Chem 1999, 274:10681-10684.
12. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790.
13. Rubinfeld B., Robbins P., El-Gamil M., Albert I., Porfiri E., Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997, 275:1790-1792.
14. Abecasis G.R., Auton A., Brooks L.D., DePristo M.A., Durbin R.M., Handsaker R.E., et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012, 491:56-65.
15. Anastas J.N., Moon R.T. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 2013, 13:11-26.
16. Papkoff J., Rubinfeld B., Schryver B., Polakis P. Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol. Cell. Biol 1996, 16:2128-2134.
17. Amit S., Hatzubai A., Birman Y., Andersen J.S., Ben-Shushan E., Mann M., et al. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 2002, 16:1066-1076.
18. Yost C., Torres M., Miller J.R., Huang E., Kimelman D., Moon R.T. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev 1996, 10:1443-1454.
19. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997, 16:3797-3804.
20. Huber O., Korn R., McLaughlin J., Ohsugi M., Herrmann B.G., Kemler R. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech. Dev 1996, 59:3-10.
21. Molenaar M., van de Wetering M., Oosterwegel M., Peterson-Maduro J., Godsave S., Korinek V., et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996, 86:391-399.
22. Peifer M., Sweeton D., Casey M., Wieschaus E. wingless signal and Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of Armadillo. Development 1994, 120:369-380.
23. Vasicek T.J., Zeng L., Guan X.J., Zhang T., Costantini F., Tilghman S.M. Two dominant mutations in the mouse fused gene are the result of transposon insertions. Genetics 1997, 147:777-786.
24. Zeng L., Fagotto F., Zhang T., Hsu W., Vasicek T.J., Perry W.L., et al. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997, 90:181-192.
25. Huang S.M., Mishina Y.M., Liu S., Cheung A., Stegmeier F., Michaud G.A., et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 2009, 461:614-620.
26. Fagotto F., Jho E., Zeng L., Kurth T., Joos T., Kaufmann C., et al. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J. Cell Biol 1999, 145:741-756.
27. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J. 1998, 17:1371-1384.
28. Kishida S., Yamamoto H., Hino S., Ikeda S., Kishida M., Kikuchi A. DIX domains of Dvl and axin are necessary for protein interactions and their ability to regulate beta-catenin stability. Mol. Cell. Biol 1999, 19:4414-4422.
29. Sakanaka C., Williams L.T. Functional domains of axin. Importance of the C terminus as an oligomerization domain. J. Biol. Chem 1999, 274:14090-14093.
30. Chia I.V., Costantini F. Mouse axin and axin2/conductin proteins are functionally equivalent in vivo. Mol. Cell. Biol 2005, 25:4371-4376.
31. Gluecksohn-Schoenheimer S. The effects of a lethal mutation responsible for duplications and twinning in mouse embryos. J. Exp. Zool 1949, 110:47-76.
32. Perry W.L., Vasicek T.J., Lee J.J., Rossi J.M., Zeng L., Zhang T., et al. Phenotypic and molecular analysis of a transgenic insertional allele of the mouse Fused locus. Genetics 1995, 141:321-332.
33. Yu H.M., Jerchow B., Sheu T.J., Liu B., Costantini F., Puzas J.E., et al. The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 2005, 132:1995-2005.
34. Aulehla A., Wehrle C., Brand-Saberi B., Kemler R., Gossler A., Kanzler B., et al. Wnt3a plays a major role in the segmentation clock controlling somitogenesis. Dev. Cell 2003, 4:395-406.
35. Jho E.H., Zhang T., Domon C., Joo C.K., Freund J.N., Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol 2002, 22:1172-1183.
36. Leung J.Y., Kolligs F.T., Wu R., Zhai Y., Kuick R., Hanash S., et al. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J. Biol. Chem 2002, 277:21657-21665.
37. Lee E., Salic A., Kruger R., Heinrich R., Kirschner M.W. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol 2003, 1:E10.
38. Lipton L., Tomlinson I. The genetics of FAP and FAP-like syndromes. Fam. Cancer 2006, 5:221-226.
39. Fearnhead N.S., Wilding J.L., Winney B., Tonks S., Bartlett S., Bicknell D.C., et al. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc. Natl Acad. Sci. U.S.A. 2004, 101:15992-15997.
40. Webster M.T., Rozycka M., Sara E., Davis E., Smalley M., Young N., et al. Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes Chromosomes Cancer 2000, 28:443-453.
41. Smalley M.J., Sara E., Paterson H., Naylor S., Cook D., Jayatilake H., et al. Interaction of axin and Dvl-2 proteins regulates Dvl-2-stimulated TCF-dependent transcription. EMBO J. 1999, 18:2823-2835.
42. Koch A., Weber N., Waha A., Hartmann W., Denkhaus D., Behrens J., et al. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas. J. Pathol 2004, 204:546-554.
43. Suraweera N., Robinson J., Volikos E., Guenther T., Talbot I., Tomlinson I., et al. Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines. Int. J. Cancer 2006, 119:1837-1842.
44. Thorstensen L., Lind G.E., Lovig T., Diep C.B., Meling G.I., Rognum T.O., et al. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia 2005, 7:99-108.
45. Liu W., Dong X., Mai M., Seelan R.S., Taniguchi K., Krishnadath K.K., et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat. Genet 2000, 26:146-147.
46. Domingo E., Espin E., Armengol M., Oliveira C., Pinto M., Duval A., et al. Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Genes Chromosomes Cancer 2004, 39:138-142.
47. Kim M.S., Kim S.S., Ahn C.H., Yoo N.J., Lee S.H. Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability. Hum. Pathol 2009, 40:58-64.
48. Koinuma K., Yamashita Y., Liu W., Hatanaka H., Kurashina K., Wada T., et al. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene 2006, 25:139-146.
49. Peterlongo P., Howe L.R., Radice P., Sala P., Hong Y.J., Hong S.I., et al. Germline mutations of AXIN2 are not associated with nonsyndromic colorectal cancer. Hum. Mutat 2005, 25:498-500.
50. Lejeune S., Guillemot F., Triboulet J.P., Cattan S., Mouton C., Group P., et al. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. Hum. Mutat 2006, 27:1064.
51. Rivera B., Perea J., Sanchez E., Villapun M., Sanchez-Tome E., Mercadillo F., et al. A novel AXIN2 germline variant associated with attenuated FAP without signs of oligondontia or ectodermal dysplasia. Eur. J. Hum. Genet 2013, 22:423-426.
52. Taniguchi K., Roberts L.R., Aderca I.N., Dong X., Qian C., Murphy L.M., et al. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 2002, 21:4863-4871.
53. Khan N.P., Pandith A.A., Hussain M.U., Yousuf A., Khan M.S., Wani K.A., et al. Novelty of Axin 2 and lack of Axin 1 gene mutation in colorectal cancer: a study in Kashmiri population. Mol. Cell. Biochem 2011, 355:149-155.
54. Lammi L., Arte S., Somer M., Jarvinen H., Lahermo P., Thesleff I., et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am. J. Hum. Genet 2004, 74:1043-1050.
55. Marvin M.L., Mazzoni S.M., Herron C.M., Edwards S., Gruber S.B., Petty E.M. AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome. Am. J. Med. Genet. A 2011, 155A:898-902.
56. Gonnet G.H., Cohen M.A., Benner S.A. Exhaustive matching of the entire protein sequence database. Science 1992, 256:1443-1445.
57. Shimizu Y., Ikeda S., Fujimori M., Kodama S., Nakahara M., Okajima M., et al. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer 2002, 33:73-81.
58. Jin L.H., Shao Q.J., Luo W., Ye Z.Y., Li Q., Lin S.C. Detection of point mutations of the Axin1 gene in colorectal cancers. Int. J. Cancer 2003, 107:696-699.
59. Matsuzaki K., Deng G., Tanaka H., Kakar S., Miura S., Kim Y.S. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer. Clin. Cancer Res 2005, 11:8564-8569.
60. Muto Y., Maeda T., Suzuki K., Kato T., Watanabe F., Kamiyama H., et al. DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability. BMC Cancer 2014, 14:466.
61. Kingston J.E., Draper G.J., Mann J.R. Hepatoblastoma and polyposis coli. Lancet 1982, 1:457.
62. Miao J., Kusafuka T., Udatsu Y., Okada A. Sequence variants of the Axin gene in hepatoblastoma. Hepatol Res 2003, 25:174-179.
63. Satoh S., Daigo Y., Furukawa Y., Kato T., Miwa N., Nishiwaki T., et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet 2000, 24:245-250.
64. Feng G.J., Cotta W., Wei X.Q., Poetz O., Evans R., Jarde T., et al. Conditional disruption of Axin1 leads to development of liver tumors in mice. Gastroenterology 2012, 143:1650-1659.
65. Kanzaki H., Ouchida M., Hanafusa H., Yano M., Suzuki H., Aoe M., et al. Single nucleotide polymorphism of the AXIN2 gene is preferentially associated with human lung cancer risk in a Japanese population. Int. J. Mol. Med 2006, 18:279-284.
66. Olson J.E., Wang X., Pankratz V.S., Fredericksen Z.S., Vachon C.M., Vierkant R.A., et al. Centrosome-related genes, genetic variation, and risk of breast cancer. Breast Cancer Res. Treat 2011, 125:221-228.
67. Wang X., Goode E.L., Fredericksen Z.S., Vierkant R.A., Pankratz V.S., Liu-Mares W., et al. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol. Biomarkers Prev 2008, 17:2101-2108.
68. Wang X.P., Fan J. Molecular genetics of supernumerary tooth formation. Genesis 2011, 49:261-277.
69. Wu Z.Q., Brabletz T., Fearon E., Willis A.L., Hu C.Y., Li X.Y., et al. Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity. Proc. Natl Acad. Sci. U.S.A. 2012, 109:11312-11317.
70. Jeon S.H., Yoon J.Y., Park Y.N., Jeong W.J., Kim S., Jho E.H., et al. Axin inhibits extracellular signal-regulated kinase pathway by Ras degradation via beta-catenin. J. Biol. Chem 2007, 282:14482-14492.
71. Kim S.E., Yoon J.Y., Jeong W.J., Jeon S.H., Park Y., Yoon J.B., et al. H-Ras is degraded by Wnt/beta-catenin signaling via beta-TrCP-mediated polyubiquitylation. J. Cell Sci 2009, 122:842-848.
72. Zhang Y., Neo S.Y., Wang X., Han J., Lin S.C. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling. J. Biol. Chem 1999, 274:35247-35254.